|
02 Jun 2007 |
Arrowhead subsidiary, Insert, publishes interim Phase I data from human clinical trials for new cancer drug
|
|
02 Jun 2007 |
Abbott Submits XIENCE(TM) V Everolimus Eluting Coronary Stent System Application for U.S. FDA Approval
|
|
01 Jun 2007 |
Indevus Announces Authorization for Approval of VANTAS(R) in Selected European Countries
|
|
01 Jun 2007 |
Wockhardt gets US FDA nod to enter the $680 million Lamisil market
|
|
01 Jun 2007 |
Medarex Announces Collaborative Research Agreement with Mitsubishi Pharma
|
|
01 Jun 2007 |
Skyepharma PLC - Twice daily ZYFLO CR(TM) (zileuton) extended-release tablets approved by the FDA for asthma
|
|
01 Jun 2007 |
Northstar Neuroscience Announces the Completion of Subject Enrollment and Randomization in the EVEREST Pivotal Trial for Upper Extremity Motor Recovery in Stroke Survivors
|
|
01 Jun 2007 |
Mylan Announces Final FDA Approval for Azithromycin Tablets
|
|
01 Jun 2007 |
Mylan Announces Tentative FDA Approval for Paroxetine Hydrochloride Extended-Release Tablets
|
|
01 Jun 2007 |
ProBioGen and Virbac signed a Licensing Agreement to use ProBioGen’s Novel Avian Cell Line AGE1 for Production of Biological Products
|
|
01 Jun 2007 |
Advanced Cell Technology Enters Into Letter of Intent to Acquire Mytogen, Inc. and Proceed with the Human Clinical Trials Utilizing Myoblasts for the Treatment of Heart Failure
|
|
01 Jun 2007 |
MIV Therapeutics Announces Start of Clinical Trial Marking First Ever Human Implantation of A Hydroxyapatite Coated Stent
|
|
01 Jun 2007 |
Peregrine Pharmaceuticals Enters Into Development Collaboration with Dios Therapeutics
|
|
31 May 2007 |
IMPAX Receives Final FDA Approval for Generic Xanax(R) XR Extended Release Tablets
|
|
31 May 2007 |
Novacea and Schering-Plough Enter into Worldwide Development and Commercialization Agreement for Asentar, a Novel Treatment for Prostate Cancer
|
|
31 May 2007 |
BioWa and Takeda announce licensing of BioWa's POTELLIGENT(R) technology for use in antibody research and development
|
|
31 May 2007 |
Mylan Announces Final FDA Approval for Fluoxetine Capsules USP, 40 mg
|
|
31 May 2007 |
Mersana Therapeutics, Inc. Initiates Phase I Trial of Anti-Cancer Agent, XMT-1001, in Solid Tumors
|
|
31 May 2007 |
CeNeRx BioPharma, Inc. Announces Agreement With PharmaNess Neuroscience to Develop Novel Cannabinoid Compounds
|
|
30 May 2007 |
Positive Final Data from HyCAMPTM Phase II Trial in Metastatic Colorectal Cancer
|
|
30 May 2007 |
Genzyme Corporation to Acquire Bioenvision, Inc.
|
|
30 May 2007 |
Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec(R)
|
|
30 May 2007 |
Angiotech initiates european trial examining the Vascular Wrapâ„¢ paclitaxel-eluting mesh for dialysis patients with end-stage renal disease
|
|
29 May 2007 |
Ranbaxy expands its presence in the us dermatology market
|
|
29 May 2007 |
Miraculins Announces Positive Final Results in Pivotal Prostate Cancer Biomarker Study
|
